Rethinking Training: The Benefits of Embracing ‘Desirable Difficulties’
Four strategies for implementing this approach in clinical trial staff and site training. Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc.
Four strategies for implementing this approach in clinical trial staff and site training. Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc.
Four strategies for implementing this approach in clinical trial staff and site training. Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc.
Ready has powered more than 1,000,000 user sessions with clinical professionals from over 90 countries to become the preferred study training tool for over 80% of site personnel.
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.
Trial leaders recognize traditional site initiation processes often lead to excessive delays but have struggled to adapt and improve.
Learn the value of slow thinking in enhancing decision-making and outcomes in clinical research and beyond.
Analyses of 95,724 clinician learners across CNS-related conditions demonstrated significant knowledge gaps and increases in clinical mastery, learn more with ArcheMedX at the CNS Summit
Explore how behavioral science can revolutionize clinical trial methodologies and overcome operational challenges. Dive deep into the interplay between human behavior and clinical research with insights from Dr. Brian McGowan and the ArcheMedX team.
Earlier this month I had the honor of presenting our research at the 2023 Nudges In Healthcare Symposium and I can not recommend the experience
How can you minimize the performance risks given the complexities of a clinical trial and be ready to effectively conduct your next study?
Analyses of 42,656 clinician learners across 69 CNS-related educational activities reveals clinicians may be unprepared to effectively conduct clinical trials Charlottesville, VA (PRWeb) November 16,
2021 was a historic year in the battle to defeat cancer. More novel cancer treatments became available than ever before with the number of Oncology
It should come as little surprise that the rise in decentralized trials (DCTs) and increase in study complexities have magnified performance demands across clinical trial
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
Get new original content and a hand-curated selection of the best life science articles from around the web directly in your inbox. Subscribe to The ArcheMedX Clinical Research Newsletter
See how ArcheMedX applies behavioral science to transform learning and generate actionable insights